SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.230+0.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tktrimbath who wrote (329)5/8/2001 7:27:55 PM
From: Mike McFarlandRead Replies (1) of 557
 
This should get you started on "lysosomal" google.com

Thanks for sharing your notes!

I'd hoped to hear some nifty E1A tidbit,
but was disappointed. A rather short meeting,
will have to watch the CIBC webcast.

I do not see Tgen at ASCO:
targen.com
...maybe next year. I don't know why they would
show us that tumor slide if they did not want us
to stay tuned in for future news on E1a.

The 'multiple pathway' slide did set up a weak
echo in my mostly empty skull:

Earlier this year in a Yahoo press release we saw this:
One of the most exciting aspects of E1A gene therapy for cancer is the multiple pathways through which E1A exerts its anti-proliferative effects, said Mien-Chie Hung

google.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext